lamivudine has been researched along with Hepatoblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korba, BE | 1 |
| Boyd, MR; Korba, BE | 1 |
| Girardet, JL; Gosselin, G; Imbach, JL; Korba, BE; Périgaud, C | 1 |
3 other study(ies) available for lamivudine and Hepatoblastoma
| Article | Year |
|---|---|
In vitro evaluation of combination therapies against hepatitis B virus replication.
Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine | 1996 |
Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
Topics: Acyclovir; Antiviral Agents; Cell Line; Dideoxynucleosides; DNA-Directed DNA Polymerase; Guanine; Hepatitis B virus; Hepatoblastoma; Humans; Lamivudine; Microbial Sensitivity Tests; Virus Replication | 1996 |
The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
Topics: Acyclovir; Antiviral Agents; Drug Evaluation, Preclinical; Drug Synergism; Hepatitis B virus; Hepatoblastoma; Humans; Lamivudine; Liver Neoplasms; Microbial Sensitivity Tests; Organophosphonates; Prodrugs; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1999 |